Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Building Materials

Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Ahmedabad, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.

Revenue projections:

Revenue projections for AMBUJACEM
Revenue projections for AMBUJACEM

AMBUJACEM's revenue is forecasted to dip below last year's figures, raising concerns for investors who are typically wary of declining financial performance. Such drops can directly affect the company's bottom line, potentially leading to a decrease in overall profitability, making investors more cautious in their decisions.

Financial Ratios:

currentRatio 1.047000
forwardPE 27.176022
debtToEquity 1.205000
earningsGrowth 0.749000
revenueGrowth 0.072000
grossMargins 0.570210
operatingMargins 0.064510
trailingEps 19.070000
forwardEps 15.601990

With a current ratio of 1.047, AMBUJACEM has the liquidity needed to easily service its short-term debt. The company's cash reserves and current assets are sufficient, indicating that AMBUJACEM is in a strong position to meet its immediate financial obligations without difficulty.
AMBUJACEM's Forward PE is in a favorable range, meaning its stock price compares well with its earnings and isn't overpriced. This leaves room for growth, making it a compelling opportunity for investors looking to benefit from potential future gains.
With AMBUJACEM's forward EPS lower than its trailing EPS, the company is expected to experience a drop in profitability. This suggests a potential slowdown in financial performance compared to the previous year.

Price projections:

Price projections for AMBUJACEM
Price projections for AMBUJACEM

Price projections for AMBUJACEM have been revised downward over time, signaling decreasing optimism about the company's outlook. Analysts appear to be adjusting their expectations as concerns about future performance grow.

Recommendation changes over time:

Recommendations trend for AMBUJACEM
Recommendations trend for AMBUJACEM


Recent analysis shows a strong buy bias for AMBUJACEM, encouraging investors to view it as a solid investment option. The positive sentiment surrounding AMBUJACEM suggests it could be an attractive place to allocate funds, motivating potential investors to consider the stock as a valuable part of their portfolio.